Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
The 2027-2032 World Outlook for Active Ingredients
US$ 1,195.00
This study covers the world outlook for active ingredients across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
288 pages
The 2027-2032 World Outlook for Actual Sugar Excipients
US$ 1,195.00
This study covers the world outlook for actual sugar excipients across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for ADME-Toxicology Testing
US$ 1,195.00
This study covers the world outlook for ADME-toxicology testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Albumin (as Excipient)
US$ 1,195.00
This study covers the world outlook for albumin (as excipient) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Anaesthesia Drugs
US$ 1,195.00
This study covers the world outlook for anaesthesia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
288 pages
The 2027-2032 World Outlook for Animal Gelatin Capsules
US$ 1,195.00
This study covers the world outlook for animal gelatin capsules across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Antibacterial in Agriculture
US$ 1,195.00
This study covers the world outlook for antibacterial in agriculture across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
287 pages
The 2027-2032 World Outlook for Antidiarrheal Drugs
US$ 1,195.00
This study covers the world outlook for antidiarrheal drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Antiemetics
US$ 1,195.00
This study covers the world outlook for antiemetics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Bioinert Medical Ceramics
US$ 1,195.00
This study covers the world outlook for bioinert medical ceramics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Biologics Safety Testing
US$ 1,195.00
This study covers the world outlook for biologics safety testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Biopharmaceutical Logistics
US$ 1,195.00
This study covers the world outlook for biopharmaceutical logistics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Branded Generics
US$ 1,195.00
This study covers the world outlook for branded generics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
288 pages
The 2027-2032 World Outlook for Calcitriol
US$ 1,195.00
This study covers the world outlook for calcitriol across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the c...
January 2026
287 pages
The 2027-2032 World Outlook for Cannabidiol
US$ 1,195.00
This study covers the world outlook for cannabidiol across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Cannabis
US$ 1,195.00
This study covers the world outlook for cannabis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the cou...
January 2026
287 pages
The 2027-2032 World Outlook for Cannabis Extracts
US$ 1,195.00
This study covers the world outlook for cannabis extracts across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Cannabis-Marijuana
US$ 1,195.00
This study covers the world outlook for cannabis-marijuana across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Cannabis Oils
US$ 1,195.00
This study covers the world outlook for cannabis oils across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
The 2027-2032 World Outlook for Cannabis Testing
US$ 1,195.00
This study covers the world outlook for cannabis testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Cannabis Testing Products
US$ 1,195.00
This study covers the world outlook for cannabis testing products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Capsule Filling Equipment
US$ 1,195.00
This study covers the world outlook for capsule filling equipment across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Carglumic Acid Tablets
US$ 1,195.00
This study covers the world outlook for carglumic acid tablets across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Children's Medicines
US$ 1,195.00
This study covers the world outlook for children's medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
288 pages
The 2027-2032 World Outlook for Clinical Trial Consumables
US$ 1,195.00
This study covers the world outlook for clinical trial consumables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
The 2027-2032 World Outlook for Clinical Trial Imaging
US$ 1,195.00
This study covers the world outlook for clinical trial imaging across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Clinical Trial Management
US$ 1,195.00
This study covers the world outlook for clinical trial management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Clinical Trial Packaging
US$ 1,195.00
This study covers the world outlook for clinical trial packaging across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Clinical Trials
US$ 1,195.00
This study covers the world outlook for clinical trials across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Clostridium Vaccines
US$ 1,195.00
This study covers the world outlook for clostridium vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Clozapine
US$ 1,195.00
This study covers the world outlook for clozapine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co...
January 2026
287 pages